National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Gastric Cancer Treatment (PDQ®)     
Last Modified: 05/16/2008
Health Professional Version
Stage 0 Gastric Cancer

Current Clinical Trials

Standard treatment options:

  • Surgery.

Stage 0 is gastric cancer confined to mucosa. Experience in Japan, where stage 0 is diagnosed frequently, indicates that more than 90% of patients treated by gastrectomy with lymphadenectomy will survive beyond 5 years. An American series has confirmed these results.[1]

Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage 0 gastric cancer 1. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site 2.

References

  1. Green PH, O'Toole KM, Slonim D, et al.: Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am J Med 85 (5): 658-61, 1988.  [PUBMED Abstract]



Table of Links

1http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?diagnosis=42595&tt=1&a
mp;format=2&cn=1
2http://www.cancer.gov/clinicaltrials